You are here: Industry Insights > Clinical Trial

News List

US, India lead in COVID-19 clinical trials benefitted by large patient pools: GlobalData expresspharma
April 09, 2021
The US is running the highest number of COVID-19 clinical trials in the world, according to the clinical trial database by GlobalData. As of early March, the country saw 823 trials. This was followed by India at 491.
Clinical trial completion rates decline during COVID-19 pandemic worldpharmanews
April 08, 2021
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers' ability to finish trials. Study completion rates dropped ...
Recro Pharma Expands Business Development Team contractpharma
April 06, 2021
Recro Pharma Inc. has strengthened the company’s business development team to support its strategic objective of expanding and diversifying its customer base.
Resumed clinical trials will grow gradually with COVID-19 vaccine rollout: GlobalData expresspharma
March 31, 2021
With the expected decrease in monthly COVID-19 cases due to increasing vaccinations in countries such as the US and the UK, GlobalData expects clinical trials to resume more quickly in these countries.
300 per cent increase in companies conducting endometriosis clinical trials since 2010: GlobalData expresspharma
March 30, 2021
Bayer, Ferring International and AbbVie were among the most highly active sponsors with 21, 11 and seven trials, respectively.
Report urges pharma companies to utilise synthetic data in clinical trials pharmatimes
March 25, 2021
A new report from Phesi and Accenture is encouraging pharmaceutical companies to utilise synthetic data in clinical trials.
Low patient accrual rates cause termination of over 25 per cent rare disease trials: GlobalData expresspharma
March 11, 2021
Difficulties with patient recruitment for rare disease clinical trials could be mitigated by the use of virtual trials.
Ivermectin not beneficial to symptom resolution in mild COVID-19 patients europeanpharmaceuticalreview
March 08, 2021
In a trial of over 400 adult patients with mild COVID-19, ivermectin did not significantly improve the time to symptom resolution compared to placebo.
Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA pharmatimes
March 05, 2021
Updated COVID-19 vaccines that are modified in response to new variants will not require a brand new approval or ‘lengthy’ clinical studies to receive authorisation, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced.
Parexel and NeoGenomics announce partnership to improve clinical trials expresspharma
February 25, 2021
The companies will collaborate to optimise study designs and speed up patient matching in oncology clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page